Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.

British journal of haematology - 1 May 2018

Kurt Habibe, Khoury Joseph D, Medeiros L Jeffrey, Huh Yang O

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blast Crisis
Share to Dendritic Cells
Share to Dioxygenases
Share to DNA (Cytosine-5-)-Methyltransferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methyltransferase 3A

Share to Leukemia, Myeloid, Acute

Share to Plasma Cells

Share to Proto-Oncogene Proteins c-myc

Source

Identifiers

PMID: 29411884
DOI: 10.1111/bjh.15128

Genes

MYC
TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.PMID 29411884Read ↗

Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.Semantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasmSemantic proximity Read ↗

Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.Semantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal originSemantic proximity Read ↗

Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.Semantic proximity Read ↗

TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasmSemantic proximity Read ↗

Neoplasms derived from plasmacytoid dendritic cells.Semantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm: Updates in Diagnostic and Molecular Pathology.Semantic proximity Read ↗

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.Semantic proximity Read ↗

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).Semantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm With De Novo TET2 and KDM6A Mutations.Semantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm in Children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.